Variant report

Variant	esv3330983
Chromosome Location	chr14:104550899-104552997
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:16)
CpG islands
(count:549)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:16 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr14:104551524-104551744	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr14:104551527-104551762	K562	blood:	n/a	n/a
3	CTCF	chr14:104551586-104551749	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr14:104551440-104551590	SAEC	small airway:	n/a	n/a
5	CTCF	chr14:104551639-104551711	MCF-7	breast:	n/a	n/a
6	E2F6	chr14:104551295-104551756	H1-hESC	embryonic stem cell:	n/a	n/a
7	MAX	chr14:104551334-104551789	H1-hESC	embryonic stem cell:	n/a	chr14:104551690-104551700 chr14:104551514-104551525
8	MAX	chr14:104551299-104551742	H1-hESC	embryonic stem cell:	n/a	chr14:104551690-104551700 chr14:104551514-104551525
9	MAZ	chr14:104551605-104551733	K562	blood:	n/a	chr14:104551690-104551700
10	POLR2A	chr14:104551445-104551510	H1-hESC	embryonic stem cell:	n/a	n/a
11	POLR2A	chr14:104552723-104552725	MCF-7	breast:	n/a	n/a
12	POLR2A	chr14:104551526-104551644	H1-hESC	embryonic stem cell:	n/a	n/a
13	POLR2A	chr14:104552542-104552979	K562	blood:	n/a	n/a
14	POLR2A	chr14:104552220-104552308	K562	blood:	n/a	n/a
15	POLR2A	chr14:104552787-104552829	Hela-S3	cervix:	n/a	n/a
16	RAD21	chr14:104551493-104551740	H1-hESC	embryonic stem cell:	n/a	n/a

(count:549 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:104552209-104552259	K562	blood:	n/a
2	chr14:104552209-104552259	MCF10A-Er-Src	breast:	n/a
3	chr14:104552397-104552447	GM06990	blood:	n/a
4	chr14:104551553-104551603	NB4	blood:	n/a
5	chr14:104552034-104552084	NHDF-neo	bronchial:	n/a
6	chr14:104552397-104552447	AoSMC	blood vessel:	n/a
7	chr14:104552034-104552084	PFSK-1	brain:	n/a
8	chr14:104551553-104551603	AoSMC	blood vessel:	n/a
9	chr14:104551884-104551934	Caco-2	colon:	n/a
10	chr14:104550915-104550965	LNCaP	prostate:	n/a
11	chr14:104552032-104552082	ProgFib	skin:	n/a
12	chr14:104551867-104551917	HepG2	liver:	n/a
13	chr14:104552032-104552082	GM19239	blood:	n/a
14	chr14:104552034-104552084	MCF-7	breast:	n/a
15	chr14:104552034-104552084	GM06990	blood:	n/a
16	chr14:104552397-104552447	K562	blood:	n/a
17	chr14:104551867-104551917	NH-A	brain:	n/a
18	chr14:104552034-104552084	GM12878	blood:	n/a
19	chr14:104552034-104552084	T-47D	breast:	n/a
20	chr14:104552397-104552447	SK-N-SH_RA	brain:	n/a
21	chr14:104550970-104551020	HMEC	breast:	n/a
22	chr14:104552209-104552259	ovcar-3	ovarian:	n/a
23	chr14:104551884-104551934	AG09319	gingival:	n/a
24	chr14:104552032-104552082	SK-N-MC	brain:	n/a
25	chr14:104551553-104551603	U87	brain:	n/a
26	chr14:104551867-104551917	HCM	heart:	n/a
27	chr14:104552032-104552082	GM12892	blood:	n/a
28	chr14:104551867-104551917	HRE	kidney:	n/a
29	chr14:104551553-104551603	SK-N-MC	brain:	n/a
30	chr14:104552034-104552084	HIPEpiC	eye:	n/a
31	chr14:104550970-104551020	AG09319	gingival:	n/a
32	chr14:104550915-104550965	GM06990	blood:	n/a
33	chr14:104551867-104551917	MCF-7	breast:	n/a
34	chr14:104552032-104552082	HRE	kidney:	n/a
35	chr14:104551867-104551917	GM19239	blood:	n/a
36	chr14:104550915-104550965	Caco-2	colon:	n/a
37	chr14:104550970-104551020	HRCEpiC	kidney:	n/a
38	chr14:104551553-104551603	BJ	skin:	n/a
39	chr14:104550970-104551020	GM19239	blood:	n/a
40	chr14:104552034-104552084	IMR90	lung:	fetal
41	chr14:104552209-104552259	HUVEC	blood vessel:	n/a
42	chr14:104550915-104550965	PrEC	prostate:	n/a
43	chr14:104551867-104551917	ProgFib	skin:	n/a
44	chr14:104550915-104550965	PFSK-1	brain:	n/a
45	chr14:104550915-104550965	T-47D	breast:	n/a
46	chr14:104550915-104550965	CMK	blood:	n/a
47	chr14:104552032-104552082	HRPEpiC	eye:	n/a
48	chr14:104552397-104552447	HRE	kidney:	n/a
49	chr14:104550915-104550965	SK-N-SH_RA	brain:	n/a
50	chr14:104551884-104551934	HCT-116	colon:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:104547299..104551387-chr14:104572829..104576125,4	MCF-7	breast:
2	chr14:104545223..104554915-chr14:104580388..104589598,19	MCF-7	breast:
3	chr14:104541403..104547183-chr14:104547881..104551718,5	MCF-7	breast:
4	chr14:104551883..104555140-chr14:104557914..104560104,3	MCF-7	breast:
5	chr14:104550379..104556575-chr14:104558618..104564277,9	MCF-7	breast:
6	chr14:104549857..104551476-chr14:104578395..104580259,2	MCF-7	breast:
7	chr14:104551586..104553253-chr14:104557526..104560384,2	K562	blood:

No data

Variant related genes	Relation type
ASPG	TF binding region
ASPG	CpG island
ENSG00000166183	chromatin interactions
ENSG00000207568	chromatin interactions

Extended variants
information (count: 77 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:77 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs546134085	chr14:104550907-104550908	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs79139297	chr14:104550914-104550915	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs550911248	chr14:104550916-104550917	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs191812093	chr14:104550958-104550959	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs184075948	chr14:104550962-104550963	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs548592555	chr14:104550983-104550984	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs567527536	chr14:104550985-104550986	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs535483315	chr14:104550986-104550987	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs1770991	chr14:104550988-104550989	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
10	rs188420740	chr14:104551060-104551061	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs547936035	chr14:104551106-104551107	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs548866982	chr14:104551114-104551115	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs151143934	chr14:104551125-104551126	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs539632745	chr14:104551194-104551195	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs549801055	chr14:104551237-104551238	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs375134782	chr14:104551271-104551272	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs569977722	chr14:104551282-104551283	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs535081601	chr14:104551467-104551468	Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs368363180	chr14:104551503-104551504	Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs192923777	chr14:104551556-104551557	Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs374935655	chr14:104551592-104551593	Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs557432965	chr14:104551621-104551622	Enhancers Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs531177187	chr14:104551623-104551624	Enhancers Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs368702064	chr14:104551627-104551628	Enhancers Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs1770990	chr14:104551650-104551651	Enhancers Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs546418170	chr14:104551652-104551653	Enhancers Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs563020065	chr14:104551721-104551722	Enhancers Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs1770989	chr14:104551750-104551751	Enhancers Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs112093730	chr14:104551815-104551816	Bivalent/Poised TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs202045411	chr14:104551837-104551838	Bivalent/Poised TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs576707598	chr14:104551876-104551877	Bivalent/Poised TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs542176005	chr14:104551920-104551921	Bivalent/Poised TSS Weak transcription Active TSS Enhancers Bivalent Enhancer	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs562035574	chr14:104552021-104552022	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs185101048	chr14:104552028-104552029	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs115343508	chr14:104552048-104552049	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs35594439	chr14:104552054-104552055	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs564614028	chr14:104552085-104552086	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs532981359	chr14:104552117-104552118	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs549973444	chr14:104552118-104552119	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs201263343	chr14:104552149-104552150	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs190574851	chr14:104552155-104552156	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs200800276	chr14:104552159-104552160	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs548884620	chr14:104552179-104552180	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs369343488	chr14:104552247-104552248	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs577578296	chr14:104552250-104552251	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs557420910	chr14:104552300-104552301	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs150274927	chr14:104552305-104552306	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs73356388	chr14:104552320-104552321	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs371505525	chr14:104552323-104552324	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs557958073	chr14:104552341-104552342	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	17899364	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Chronic myeloid leukemia	20724749	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Colorectal cancer	16774939	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Neuroblastoma	18923191	CNVD
Barrett''s syndrome	19417022	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
cataract	16735990	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Cancer	20164920	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Biliary cancer	19435499	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	20139093	CNVD
Hepatocellular carcinoma	16750200	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Glioblastoma multiforme	21922591	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	22174824	CNVD
Non-small cell lung cancer	18320023	CNVD
Melanoma	17363583	CNVD
Prostate cancer	18632612	CNVD
Congenital heart defect	22367666	CNVD
Developmental delay	22367666	CNVD
Genitourinary abnormalities	22367666	CNVD
Intellectual disability	22367666	CNVD
Microcephaly	22367666	CNVD
Muscularhypotonia	22367666	CNVD
Ocular coloboma	22367666	CNVD
Teratozoospermia	22367666	CNVD
Cervical cancer	21062161	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	21990379	CNVD
Breast cancer	16417655	CNVD
22q11 deletion syndrome	22511897	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Schizophrenia	21399695	CNVD
Intracranial ependymoma	16609018	CNVD
Lung adenocarcinoma	17086460	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
14q deletion syndrome	22511897	CNVD
Epilepsy	22083797	CNVD
Urothelial carcinoma	21177765	CNVD
Ovarian cancer	21720365	CNVD
Cancer	17440070	CNVD
Neurocytoma	17123091	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Central neurocytomas	17123091	CNVD
Acute lymphoblastic leukemia	17315016	CNVD
Lung cancer	17086460	CNVD
Mortal	21835882	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	17426248	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:174 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:104544800-104551000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr14:104547800-104551400	Weak transcription	Spleen	Spleen
3	chr14:104548400-104552200	Enhancers	Stomach Mucosa	stomach
4	chr14:104548600-104551400	Enhancers	Colonic Mucosa	Colon
5	chr14:104548800-104551200	Weak transcription	Right Atrium	heart
6	chr14:104549000-104552200	Bivalent Enhancer	Placenta	Placenta
7	chr14:104549200-104551400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
8	chr14:104549600-104551200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr14:104549600-104554000	Weak transcription	Pancreas	Pancrea
10	chr14:104550200-104552000	Enhancers	Rectal Mucosa Donor 31	rectum
11	chr14:104550200-104552200	Enhancers	Rectal Mucosa Donor 29	rectum
12	chr14:104550400-104551000	Enhancers	Ovary	ovary
13	chr14:104550400-104551400	Enhancers	Duodenum Mucosa	Duodenum
14	chr14:104550400-104551400	Bivalent Enhancer	Fetal Intestine Large	intestine
15	chr14:104550600-104551400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
16	chr14:104550600-104551400	Bivalent Enhancer	Fetal Intestine Small	intestine
17	chr14:104550600-104551800	Enhancers	Right Ventricle	heart
18	chr14:104550600-104552000	Enhancers	Left Ventricle	heart
19	chr14:104550800-104551200	Flanking Active TSS	Fetal Heart	heart
20	chr14:104550800-104551800	Bivalent Enhancer	Fetal Muscle Leg	muscle
21	chr14:104550800-104552000	Enhancers	Liver	Liver
22	chr14:104550800-104555200	Enhancers	Gastric	stomach
23	chr14:104551000-104551200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
24	chr14:104551000-104551200	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
25	chr14:104551000-104551200	Enhancers	Brain Anterior Caudate	brain
26	chr14:104551000-104551400	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
27	chr14:104551000-104551400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
28	chr14:104551000-104551400	Weak transcription	Lung	lung
29	chr14:104551000-104551600	Flanking Active TSS	Ovary	ovary
30	chr14:104551200-104551400	Enhancers	HUES48 Cell Line	embryonic stem cell
31	chr14:104551200-104551400	Enhancers	HUES6 Cell Line	embryonic stem cell
32	chr14:104551200-104551400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr14:104551200-104551400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
34	chr14:104551200-104551400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr14:104551200-104551400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
36	chr14:104551200-104551600	Enhancers	Fetal Lung	lung
37	chr14:104551200-104551600	Enhancers	Right Atrium	heart
38	chr14:104551200-104551800	Enhancers	H1 Cell Line	embryonic stem cell
39	chr14:104551200-104552000	Bivalent Enhancer	Adipose Nuclei	Adipose
40	chr14:104551200-104552200	Enhancers	Fetal Heart	heart
41	chr14:104551200-104555000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
42	chr14:104551400-104551600	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
43	chr14:104551400-104551600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
44	chr14:104551400-104551600	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
45	chr14:104551400-104551600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
46	chr14:104551400-104551600	Bivalent Enhancer	Duodenum Mucosa	Duodenum
47	chr14:104551400-104551600	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
48	chr14:104551400-104551600	Flanking Bivalent TSS/Enh	Fetal Intestine Large	intestine
49	chr14:104551400-104551600	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
50	chr14:104551400-104551600	Bivalent Enhancer	Fetal Stomach	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links